Evidence map›Paper›PMID 41031031›Full record

ArticlebioRxiv : the preprint server for biology2024

Rapid prediction of thermodynamically destabilizing tyrosine phosphorylations in cancers.

Jaie Woodard, Zhengqing Liu, Atena Malemir Chegini, Jian Tian, Rupa Bhowmick, Subramanium Pennathur, Alireza Mashaghi, Jeffrey Brender, Sriram Chandrasekaran

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jaie WoodardDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
Zhengqing LiuDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
Atena Malemir CheginiMedical Systems Biophysics and Bioengineering, Leiden Academic Centre for Drug Research, Faculty of Science, Leiden University, 2333CC, Leiden, the Netherlands.
Jian TianState Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China.
Rupa BhowmickDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
Subramanium PennathurDepartment of Medicine and Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.
Alireza MashaghiMedical Systems Biophysics and Bioengineering, Leiden Academic Centre for Drug Research, Faculty of Science, Leiden University, 2333CC, Leiden, the Netherlands.
Jeffrey BrenderNational Institutes of Health, Bethesda, Maryland, 20892, USA.
Sriram ChandrasekaranDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0002-8405-5708

Funding

Training CoreTL1DK136046 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Laura H Mariani · 2022 to 2026
$2.5M
University of Michigan Kidney, Urology and Hematology Research Training NetworkU2CDK129445 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BENJAMIN L MARGOLIS · 2022 to 2026
$2.0M
NIDDK NIH HHS TL1 DK136046NIDDK NIH HHS U2C DK129445
6 · The paper itself

Abstract

Tyrosine phosphorylations are a prominent characteristic of numerous cancers, necessitating the use of computational tools to comprehensively analyze phosphoproteomes and identify potentially (dys)functional phosphorylations. Here we propose a machine learning-based method to predict the thermodynamic stability change resulting from tyrosine phosphorylation. Our approach, based on prediction of phosphomimetic delta-delta-G from structural features, strongly correlates with experimental mutational scanning cDNA proteolysis data (R = 0.71). We predicted the destabilizing effects of all 384,857 tyrosine residues from the Alphafold2 database. We then applied our approach to a pan-cancer phosphoproteomics dataset, comprising over 600 unique tyrosine phosphorylations across 11 cancer subtypes. We predict destabilizing phosphorylations in both oncogenes and tumor suppressors, where the former likely reflects a generalized relief of auto-inhibition or activating conformational change. We find that the number of circuit topological parallel relations with respect to residues contacting the phosphorylated site is greater for autoinhibited oncogenes than for other proteins (Wilcoxon p = 0.03). Utilizing an extreme gradient-boosting machine learning approach, we obtain an AUC of 0.85 for the prediction of autoinhibited phosphorylation states from circuit topological features. The top destabilized proteins from the pan-cancer data are enriched for chemical and oxidative stress pathways. Among metabolic proteins, highly destabilizing phosphorylations tend to occur in more peripheral proteins with lower network centrality measures (Wilcoxon p = 0.005). We predict 58% of recurrent tyrosine cancer phosphorylations to be destabilizing at the 1 kcal/mol threshold. Our approach can enable rapid screening of destabilizing phosphorylations and phosphomimetic mutations.

Identifiers

PMID41031031
PMCPMC12478365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.